Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
S H Kelkar and Company Limited (SHK.NS)
Mumbai, IN
S H Kelkar and Company Limited, in conjunction with its subsidiary entities, functions as a principal producer and purveyor of aromatic compounds, flavorings, and various aroma ingredients, serving markets primarily in India and through exports. The company's fragrance offerings are incorporated into a broad spectrum of products, including those for personal hygiene, hair care, skin treatment, cosmetics, fabric conditioning, general household use, and high-end perfumes. Concurrently, its flavors are vital components in items such as dairy products, beverages, confectionery, baked goods, pharmaceuticals, nutraceuticals, and savory dishes. S H Kelkar markets its product lines through distinct brands like SHK, Cobra, and Keva, catering to a diverse customer base that spans major domestic and international Fast-Moving Consumer Goods (FMCG) corporations, alongside specialized blenders and manufacturers within the fragrance and flavor industries. The firm, established in 1914, is headquartered in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.76% | -10.94% | -15.09% | -19.72% | -28.97% | -29.42% | -45.13% | +19.59% | -17.50% | -44.06% | -39.27% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+12.1% ★ Q1'26: +15.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-5.8% Q1'26: -98.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+1.8% Q1'26: +5.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+5.2% Q1'26: +3.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.2% Q1'26: +2.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.4% Q1'26: +3.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.26× Q1'26: 4.29× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.23B
est: 7.31B (+26.3%)
|
9.75B
est: 10.06B (-3.1%)
|
10.19B
est: 10.28B (-0.9%)
|
10.41B
est: 10.48B (-0.7%)
|
11.05B
est: 11.14B (-0.8%)
|
13.15B
est: 13.06B (+0.7%)
|
15.60B
est: 15.29B (+2.0%)
|
16.77B
est: 17.66B (-5.1%)
|
18.33B
est: 19.72B (-7.1%)
|
21.13B
est: 21.10B (+0.1%)
|
23.65B
23.65B – 23.65B
+12.1% YoY
|
26.59B
26.59B – 26.59B
+12.4% YoY
|
30.63B
30.63B – 30.63B
+15.2% YoY
|
34.43B
34.43B – 34.43B
+12.4% YoY
|
| EBITDA |
1.56B
est: 1.09B (+43.2%)
|
1.78B
est: 2.63B (-32.2%)
|
1.72B
est: 1.81B (-4.8%)
|
1.61B
est: 1.78B (-9.6%)
|
1.30B
est: 1.50B (-13.5%)
|
2.66B
est: 802.80M (+231.6%)
|
2.14B
est: 962.41M (+122.5%)
|
2.00B
est: 1.10B (+81.9%)
|
2.99B
est: 2.94B (+1.8%)
|
2.59B
est: 3.14B (-17.6%)
|
3.52B
3.52B – 3.52B
+12.1% YoY
|
3.96B
3.96B – 3.96B
+12.4% YoY
|
4.56B
4.56B – 4.56B
+15.2% YoY
|
5.13B
5.13B – 5.13B
+12.4% YoY
|
| EBIT |
1.26B
est: 747.23M (+68.8%)
|
1.56B
est: 2.51B (-37.6%)
|
1.48B
est: 1.54B (-3.3%)
|
1.30B
est: 1.29B (+1.3%)
|
790.70M
est: 1.13B (-30.2%)
|
2.05B
est: 748.37M (+173.5%)
|
1.42B
est: 897.15M (+58.6%)
|
1.20B
est: 1.03B (+16.7%)
|
2.10B
est: 2.02B (+4.1%)
|
1.64B
est: 2.16B (-23.9%)
|
2.42B
2.42B – 2.42B
+12.1% YoY
|
2.72B
2.72B – 2.72B
+12.4% YoY
|
3.13B
3.13B – 3.13B
+15.2% YoY
|
3.52B
3.52B – 3.52B
+12.4% YoY
|
| Net Income |
730.60M
est: 682.74M (+7.0%)
|
1.05B
est: 1.51B (-30.4%)
|
938.80M
est: 1.08B (-13.3%)
|
884.80M
est: 957.27M (-7.6%)
|
356.90M
est: 942.23M (-62.1%)
|
1.45B
est: 352.06M (+311.0%)
|
1.49B
est: 422.06M (+252.0%)
|
611.70M
est: 482.67M (+26.7%)
|
1.22B
est: 109.27M (+1,020.4%)
|
732.40M
est: 1.16B (-36.8%)
|
537.92M
537.92M – 537.92M
-53.6% YoY
|
606.88M
606.88M – 606.88M
+12.8% YoY
|
1.37B
1.37B – 1.37B
+125.0% YoY
|
1.89B
1.89B – 1.89B
+38.4% YoY
|
| SGA |
322.50M
est: 515.79M (-37.5%)
|
376.80M
est: 4.79B (-92.1%)
|
464.90M
est: 2.55B (-81.8%)
|
510.40M
est: 2.58B (-80.2%)
|
509.90M
est: 2.95B (-82.7%)
|
625.70M
est: 2.73B (-77.0%)
|
775.80M
est: 3.27B (-76.3%)
|
948.30M
est: 3.74B (-74.6%)
|
992.60M
est: 1.39B (-28.7%)
|
3.06B
est: 1.49B (+105.6%)
|
1.67B
1.67B – 1.67B
+12.1% YoY
|
1.88B
1.88B – 1.88B
+12.4% YoY
|
2.16B
2.16B – 2.16B
+15.2% YoY
|
2.43B
2.43B – 2.43B
+12.4% YoY
|
| EPS |
5.36
est: 4.95 (+8.3%)
|
7.25
est: 7.54 (-3.8%)
|
6.52
est: 7.70 (-15.3%)
|
6.20
est: 7.20 (-13.9%)
|
2.56
est: 4.70 (-45.5%)
|
10.48
est: 10.54 (-0.5%)
|
10.81
est: 12.00 (-9.9%)
|
4.53
est: 7.90 (-42.7%)
|
8.93
est: 0.79 (+1,027.3%)
|
5.31
est: 8.40 (-36.8%)
|
3.90
3.90 – 3.90
-53.6% YoY
|
4.40
4.40 – 4.40
+12.8% YoY
|
9.90
9.90 – 9.90
+125.0% YoY
|
13.70
13.70 – 13.70
+38.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kedar Ramesh Vaze | Group Chief Executive Officer & Whole-Time Director | 30M | male |
| Avani Mainkar | Chief Scientific Officer | — | — |
| Avik Ghosh | Executive Vice President of HR - Asia | — | male |
| Deepti Chandratre | Global Legal Counsel & Company Secretary | — | female |
| Jagdish Agarwal | Group Chief Financial Officer | — | male |
| Medha Tawde Bhagat | Executive Vice President of Fragrance Asia Corporate & Global Accounts | — | female |
| Ramakrishnan | CEO of Fragrances, Asia & U.S.A. | — | male |
| Swapneel Kore | Chief Information Officer | — | male |
| Amit Gulati | Chief Operating Officer of Asia Fragrance & Flavours | — | male |
| Vivek Kulkarni | Executive Vice President of Ingredients Division | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SHK.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
